Tax Court Denies Dividend Deduction for Indirectly Owned Foreign Subsidiaries

WASHINGTON — The U.S. Tax Court issued a significant ruling on April 8, 2026, that curtails a key tax benefit for American corporations with complex international structures. In the case of Varian Medical Systems, Inc. & Subs. v. Commissioner, the court denied a $100 million dividends received deduction (DRD) for payments from foreign subsidiaries that were not directly owned by the U.S. parent company. The decision also clarified the proper method for calculating foreign tax credit (FTC) limitations related to the 2017 tax law’s one-time transition tax. The case centered on provisions enacted as part of the Tax Cuts and Jobs Act (TCJA), which shifted the U.S. toward a territorial tax system. A central piece of that reform was Internal Revenue Code Section 245A, which generally allows U.S. corporations a 100% deduction for dividends received from their foreign subsidiaries, preventing that income from being taxed twice. However, the court’s strict interpretation of ownership requirements has now narrowed the scope of this popular deduction, creating a potential tax trap for companies with multi-tiered global operations. This ruling is a stark reminder that the complexities of post-TCJA international tax law are still being litigated and defined. For small and mid-sized businesses venturing abroad, the distinction between direct and indirect ownership of a foreign entity may seem like a minor detail, but as this case shows, it can have multi-million-dollar consequences. We often see business owners assume that tax benefits like the Section 245A deduction apply broadly across their entire corporate family, but the reality is far more granular. The court's adherence to the plain language of the statute serves as a crucial lesson: corporate structure is not just an operational decision, it is a critical tax-planning decision. Navigating these intricate rules requires specialized expertise in tax preparation and compliance. At C&S Finance Group LLC, we guide businesses through these exact challenges to ensure their international structures are optimized for U.S. tax law; learn more at csfinancegroup.com. The primary issue for the dividends received deduction was whether Varian met the holding period requirements under Section 246(c) for its lower-tier controlled foreign corporations (CFCs). According to court documents, the shares of these subsidiaries were held at all times by other, intermediate foreign corporations, not directly by the U.S.-based Varian. The company argued for a more flexible interpretation, but the Tax Court sided with the IRS, applying a strict, direct-ownership reading of the law. The court concluded that because Varian did not hold the shares of the dividend-paying CFCs directly, it was not entitled to the Section 245A deduction for the associated income, which in this case was approximately $100 million in dividends deemed received under Section 78 of the tax code. This outcome reinforces a pattern of strict statutory interpretation by both the IRS and the courts in the years following the TCJA's passage. For instance, an IRS Office of Chief Counsel Advice memorandum issued on September 6, 2024, reached a similar conclusion in a different context, finding that a CFC could not claim the deduction for a dividend received from another foreign corporation in which it held a minority interest. These actions signal that taxpayers should not expect leniency when their corporate structures do not precisely match the letter of the law. The second part of the Varian decision addressed the technical computation of the foreign tax credit disallowance under Section 245A(d). This provision is designed to prevent companies from receiving a deduction on foreign income while also claiming a tax credit for foreign taxes paid on that same income. The dispute arose in the context of the Section 965 transition tax, which imposed a one-time levy on previously untaxed accumulated foreign earnings. Varian argued for a calculation method for the FTC disallowance fraction that the court ultimately deemed “structurally flawed.” The court noted that other sections of the tax code already reduce, or apply a “haircut” to, the foreign taxes eligible for a credit in proportion to a related deduction under Section 965(c). It found that Varian’s proposed calculation failed to properly account for this haircut in the denominator of the disallowance fraction. By siding with the IRS’s methodology, the court affirmed a computational approach that prevents what it viewed as a disproportionate tax benefit, ensuring the FTC disallowance is calculated in a way that is mathematically consistent with the rest of the tax code. For U.S. companies with global footprints, this ruling underscores the critical importance of meticulous corporate structuring and tax compliance. The decision in Varian Medical Systems sets a powerful precedent that will likely influence ongoing and future audits and disputes with the IRS. Business leaders should review their international holding structures to assess their own risk in light of the court’s narrow interpretation of ownership requirements. Any planned expansions or reorganizations must now more carefully consider the direct ownership of foreign subsidiaries to ensure eligibility for key U.S. tax benefits.